CYTEK BIOSCIENCES, INC. Accounts Receivable, Allowance for Credit Loss, Recovery
CYTEK BIOSCIENCES, INC. (CTKB) reported Accounts Receivable, Allowance for Credit Loss, Recovery of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Notes › and Others › Accounts, Notes, Loans and Financing Receivable, Gross, Allowance, and Net
us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries · last filed 2025-02-28
- CYTEK BIOSCIENCES, INC. accounts receivable, allowance for credit loss, recovery for the quarter ending 2022-12-31 was $0.00.
- CYTEK BIOSCIENCES, INC. accounts receivable, allowance for credit loss, recovery for the quarter ending 2022-09-30 was $0.00.
- CYTEK BIOSCIENCES, INC. accounts receivable, allowance for credit loss, recovery for the quarter ending 2022-06-30 was $0.00.
- CYTEK BIOSCIENCES, INC. accounts receivable, allowance for credit loss, recovery for the quarter ending 2022-03-31 was $0.00.
- CYTEK BIOSCIENCES, INC. accounts receivable, allowance for credit loss, recovery for fiscal 2022 was $0.00.
- CYTEK BIOSCIENCES, INC. accounts receivable, allowance for credit loss, recovery for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- CYTEK BIOSCIENCES, INC. accounts receivable, allowance for credit loss, recovery for fiscal 2020 was $175.00K.
| Period end | Accounts Receivable, Allowance for Credit Loss, Recovery 3 month | Accounts Receivable, Allowance for Credit Loss, Recovery 6 month | Accounts Receivable, Allowance for Credit Loss, Recovery 9 month | Accounts Receivable, Allowance for Credit Loss, Recovery 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $0.00 derived: sum of 2 quarters · filed 2025-02-28 | $0.00 derived: sum of 3 quarters · filed 2025-02-28 | $0.00 10-K · filed 2025-02-28 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $0.00 10-Q · filed 2022-08-10 | ||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-12 | |||
| 2021-12-31 | $0.00 10-K · filed 2023-03-01 | |||
| 2020-12-31 | $175.00K 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |